Systematische ÜbersichtMetaanalyse
Rifaximin for outcomes beyond hepatic encephalopathy in cirrhosis: An updated systematic review and meta-analysis
World Journal of Gastroenterology · 04.11.2026
DOI: 10.3748/wjg.126421 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift World Journal of Gastroenterology, online erschienen am 04.11.2026. Verfasst von Eun Jeong Gong und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gong, E. J., & Bang, C. S. (2026). Rifaximin for outcomes beyond hepatic encephalopathy in cirrhosis: An updated systematic review and meta-analysis. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.126421
Vancouver
Gong EJ, Bang CS. Rifaximin for outcomes beyond hepatic encephalopathy in cirrhosis: An updated systematic review and meta-analysis. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.126421
BibTeX
@article{Gong2026,
author = {Gong, Eun Jeong and Bang, Chang Seok},
title = {Rifaximin for outcomes beyond hepatic encephalopathy in cirrhosis: An updated systematic review and meta-analysis},
journal = {World Journal of Gastroenterology},
year = {2026},
doi = {10.3748/wjg.126421}
}
EUVIMED